Joshua T Brumm Glycomimetics Inc (GLYC) insider trading activity

GLYC Quotes by TradingView

Joshua T Brumm is Chief Executive Officer of GLYCOMIMETICS INC. Currently has a direct ownership of 323,517 shares of GLYC, which is worth approximately $5.08 Million. The most recent transaction as insider was on Dec 15, 2025, when has been sold 55,117 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 324K
n/a 3M change
n/a 12M change
Total Value Held $5.08 Million

Joshua T Brumm Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 15 2025
BUY
Grant, award, or other acquisition
-
55,117 Added 14.56%
323,517 Ordinary Shares

Also insider at

DYN
Dyne Therapeutics, Inc. Healthcare
CEO & President
JTB

Joshua T Brumm

Chief Executive Officer
Waltham, MA

Track Institutional and Insider Activities on GLYC

Follow GLYCOMIMETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLYC shares.

Notify only if

Insider Trading

Get notified when an Glycomimetics Inc insider buys or sells GLYC shares.

Notify only if

News

Receive news related to GLYCOMIMETICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GLYC